Showing results (41-50 of 84) with videos related to
Sort By:
Pageof 9
Health Affairs (Project Hope)|August 9, 2017
Drugs Cleared Through The FDA's Expedited Review Offer Greater Gains Than Drugs Approved By Conventional ProcessJames D Chambers, Teja Thorat, Colby L Wilkinson, et al.The Milbank Quarterly|August 30, 2023
Improving Food and Drug Administration-Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated ApprovalPeter J Neumann, Elliott Crummer, James D Chambers, et al.Health Affairs (Project Hope)|December 8, 2011
Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implementPeter J Neumann, James D Chambers, Françoise Simon, et al.Orphanet Journal of Rare Diseases|February 6, 2022
Patients' access to rare neuromuscular disease therapies varies across US private insurersNikoletta M Margaretos, Komal Bawa, Natalie J Engmann, et al.Cancer Research Communications|December 1, 2025
Real-World Clinical Oncology Outcomes Associated With the Accelerated Approval PathwayTu My To, Stacey Kowal, James D Chambers, et al.Health Affairs (Project Hope)|September 3, 2024
US Commercial Plans Increase Choice Of Biosimilar And Originator Products; Market Net Prices DecreaseMolly T Beinfeld, Fariel LaMountain, William Wong, et al.The American Journal of Managed Care|October 9, 2014
Potential role of network meta-analysis in value-based insurance designJames D Chambers, Aaron Winn, Yue Zhong, et al.Journal of Managed Care & Specialty Pharmacy|September 27, 2016
Variation in Private Payer Coverage of Rheumatoid Arthritis DrugsJames D Chambers, Colby L Wilkinson, Jordan E Anderson, et al.Health Affairs (Project Hope)|November 1, 2021
Variation In Use And Content Of Prescription Drug Step Therapy Protocols, Within And Across Health PlansKelly L Lenahan, Donald E Nichols, Rebecca M Gertler, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 2, 2023
Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health PlansTianzhou Yu, Shihan Jin, Chang Li, et al.Pageof 9